• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[转移性乳腺癌大剂量甲羟孕酮治疗中游离脂肪酸和脂质的血浆浓度]

[Plasma concentrations of non-esterified fatty acids and lipids in high-dose medroxyprogesterone therapy of metastatic breast cancer].

作者信息

Hofmann M, Holzer A, Brockerhoff P, Rathgen G H

机构信息

Frauenklinik, Johannes Gutenberg-Universität, Mainz.

出版信息

Zentralbl Gynakol. 1993;115(11):495-9.

PMID:8296495
Abstract

The objective of this study was to investigate the influence of high dose MPA on serum cholesterol, triglyceride, phospholipids as well as free fatty acids given to 17 patients with metastatic breast cancer. Before the therapy, the patients with cancer revealed higher level in serum cholesterol, triglyceride, phospholipids and C 12:0, C 18:0 as we found it in the control (13 patients without cancer). There was no significant change in lipid parameters by treatment with MPA whereas cortisol decreases and insulin increases under therapy. The results are discussed under biochemical aspects.

摘要

本研究的目的是调查给予17例转移性乳腺癌患者高剂量甲羟孕酮(MPA)对血清胆固醇、甘油三酯、磷脂以及游离脂肪酸的影响。在治疗前,癌症患者的血清胆固醇、甘油三酯、磷脂以及C12:0、C18:0水平高于我们在对照组(13例无癌症患者)中所发现的水平。用MPA治疗后脂质参数无显著变化,而治疗期间皮质醇水平下降,胰岛素水平上升。从生化方面对结果进行了讨论。

相似文献

1
[Plasma concentrations of non-esterified fatty acids and lipids in high-dose medroxyprogesterone therapy of metastatic breast cancer].[转移性乳腺癌大剂量甲羟孕酮治疗中游离脂肪酸和脂质的血浆浓度]
Zentralbl Gynakol. 1993;115(11):495-9.
2
[Plasma lipoprotein fractions in high-dose medroxyprogesterone acetate therapy in metastatic breast cancer].
Gynakol Rundsch. 1991;31(4):189-200.
3
[Postoperative changes in serum lipid levels of breast cancer and adjuvant chemotherapy].[乳腺癌血清脂质水平的术后变化及辅助化疗]
Gan To Kagaku Ryoho. 2004 Oct;31(10):1517-24.
4
[Relation of blood lipids and insulin to body fat content, body surface area and state of the subcutaneous fatty tissue in patients with breast and lung cancer].[乳腺癌和肺癌患者血脂及胰岛素与体脂含量、体表面积和皮下脂肪组织状态的关系]
Vopr Onkol. 1985;31(1):44-51.
5
Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.氨鲁米特对醋酸甲羟孕酮血浆水平的影响:及其与血清皮质醇的相关性。
Cancer Treat Rep. 1985 Jan;69(1):85-90.
6
Medroxyprogesterone acetate treatment reduces serum interleukin-6 levels in patients with metastatic breast carcinoma.
Cancer. 1996 Dec 1;78(11):2346-52.
7
[Chemo-endocrine therapy with high dose medroxyprogesterone acetate for recurrent or advanced breast cancer].
Gan To Kagaku Ryoho. 1993 Nov;20(14):2165-9.
8
Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.辅酶Q10、核黄素和烟酸对他莫昔芬治疗的绝经后乳腺癌患者的改善作用,特别涉及脂质和脂蛋白
Clin Biochem. 2007 Jun;40(9-10):623-8. doi: 10.1016/j.clinbiochem.2007.02.003. Epub 2007 Mar 19.
9
Plasma concentrations of lipids and lipoproteins in newborn kids and female Baladi goats during late pregnancy and onset of lactation.妊娠后期及泌乳初期新生羔羊和雌性巴拉迪山羊血浆中脂质和脂蛋白的浓度。
Dtsch Tierarztl Wochenschr. 1998 Jan;105(1):6-9.
10
Oral high-dose medroxyprogesterone acetate treatment for recurrent breast cancer.
Anticancer Res. 1995 May-Jun;15(3):1061-4.